Whitehawk Therapeutics Inc

NASDAQ:WHWK

Biotechnology

Healthcare
$3.13 +1.42%

+$0.06 today

Market cap
$184.70M
Beta
0.77
P/E (TTM)
-2.6
EPS (TTM)
-$1.67
52W Low $1.57High $5.50

Volume 0.28M

Average 0.31M

WHWK Total Liabilities

Everything the company owes to creditors and other parties.

Whitehawk Therapeutics IncNASDAQ: WHWK

Total Liabilities · Q1 FY2026 · quarter ended Mar 2026

Total liabilities falls 9.9% from a year ago

Total liabilities stood at $11.06M at the end of Q1 FY2026, down 9.9% from a year earlier and down 23.9% from the prior quarter. Over 3 fiscal years it compounded at -17.5% a year.

Context

  • Total liabilities amounted to 8.7% of total assets at the end of Q1 FY2026, up 3.4 pp from a year earlier.
  • Total liabilities increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether total liabilities keeps falling in the next quarterly balance sheet after a -9.9% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$11.06M-23.9% QoQ
Last fiscal yearDec 2025
$14.52M-18.6% YoY
Year agoMar 2025
$12.27M-9.9% since
Total Liabilities past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-9.9%——
1 year-18.6%——
3-year CAGR-17.5%——
5-year CAGR——
10-year CAGR——

Total Liabilities history

USD · from the balance sheet

Latest · FY2025
14.52M USD
Year-over-year change
-18.6%
4-year CAGR
-9.4%

Total Liabilities vs competitors

How WHWK compares with its peers on the latest reported figures

  • Peers report in different currencies, so total liabilities is compared through growth and share of total assets rather than absolute size.
  • Its year-over-year change of -9.9% is the 7th highest of 9, against a peer median of +16.7%.
  • Total liabilities amounts to 8.7% of total assets for WHWK, versus a peer median of 23.1%.
WHWK Competitors
Total Liabilities for WHWK and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
MGNXMacroGenics, Inc.Mar 2026$196.68M USD+35.2%+10.9%90.3%
ZNTLZentalis Pharmaceuticals, Inc.Mar 2026$70.39M USD-20.6%-15.2%27.8%
CLNNClene Inc.Mar 2026$40.47M USD+33.6%-4.7%186.8%
PLRXPliant Therapeutics, Inc.Mar 2026$37.43M USD-57.3%+5.7%18.5%
OVIDOvid Therapeutics Inc.Mar 2026$27.36M USD+22.3%-4.1%12.1%
ONCYOncolytics Biotech Inc.Mar 2026CA$13.29M CAD+0.6%+13.0%162.9%
IMMXImmix Biopharma, Inc.Mar 2026$11.45M USD+11.2%+84.9%12.0%
WHWKWhitehawk Therapeutics IncMar 2026$11.06M USD-9.9%-17.5%8.7%
CNTXContext Therapeutics Inc.Mar 2026$6.66M USD+235.7%+35.7%11.3%
Peer median (excluding WHWK) —+16.7%+8.3%23.1%

Competitors are the stored peer set for WHWK. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents148.99M39.02M62.89M28.67M37.57M
Short-term Investments0133.54M45.96M18.57M108.13M
Net Receivables01.86M5.49M5.9M0
Inventory01.86M6.43M5.31M0
Other Current Assets003.83M03.32M
Total Current Assets151.27M180.03M124.59M61.29M149.01M
Property, Plant & Equipment (Net)614K2.03M5.97M7.63M3K
Goodwill00000
Intangible Assets3.81M0000
Long-term Investments00000
Tax Assets00000
Other Non-current Assets2.21M2.18M1.87M1.4M1.81M
Total Non-current Assets6.64M4.21M7.84M9.03M1.82M
Total Assets157.91M184.24M132.42M70.32M150.83M
Account Payables6.44M3.52M5.9M2.16M917K
Short-term Debt00000
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities1.47M1.57M3.08M64K3.16M
Total Current Liabilities15.27M18.84M26.4M17.07M14.52M
Long-term Debt00000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities5.76M5.76M0202K0
Total Non-current Liabilities6.23M7.02M833K767K0
Total Liabilities21.5M25.86M27.23M17.84M14.52M
Common Stock2K2K2K2K4K
Retained Earnings(142.69M)(203.2M)(268.96M)(332.65M)(353.25M)
Accumulated OCI0(115K)27K16K120K
Other Stockholders Equity00000
Minority Interest00000
Total Equity136.41M158.38M105.2M52.48M136.31M
Total Debt605K1.66M1.27M833K0
Net Debt(148.38M)(37.36M)(61.62M)(27.84M)(37.57M)

Whitehawk Therapeutics Inc

NASDAQ:WHWK

Intrinsic Alpha fair value

Locked

Current Price

$3.13

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.